OneOncology Names Ian Wong Chief Operating Officer

NASHVILLE, Tenn., July 31, 2025 /PRNewswire/ -- OneOncology, a physician-led national platform empowering independent oncology practices, is pleased to announce that Ian Wong has been appointed Chief Operating Officer (COO).

Wong, currently the CEO of United Urology Group, a subsidiary of OneOncology, will now have responsibility for operations across OneOncology's unified platform as a OneOncology executive. A seasoned healthcare operations professional, Wong has spent over 20 years in diverse leadership roles including as Chief Operating Officer at NexCore Group, the nation's leading healthcare real estate developer, and as an Executive Vice President in a myriad of Finance, Strategy, Development, and Operating roles, at DaVita, Inc., a Fortune 200 healthcare services company.

"I'm thrilled to welcome Ian to the OneOncology executive team," said Jeff Patton, MD, CEO of OneOncology. ""Since OneOncology and United Urology Group joined forces last year, Ian has already been playing a key role within the OneOncology executive team, so this transition is a natural and exciting one and brings our two great organizations even closer together and works to cement our strategy to realize the synergies of medical oncology, urology, and radiation oncology."

Todd Stevens, who has successfully served as both OneOncology's COO and Chief Development Officer (CDO), will continue leading OneOncology's growth strategy. Stevens will also be responsible for growth across OneOncology's urology platform. 

In seven years the OneOncology platform has grown from three to 29 oncology practices with 1,750 cancer care providers, and 4 urology practices with 270 urology care providers,  caring for approximately 1 million patients. With its rapid growth, OneOncology continues to demonstrate the critical role independent medical practices play in delivering high-quality, patient-centered care that is more accessible and cost-effective than the same care delivered in institutional settings. By empowering physicians with robust technology, operational support, clinical tools, and shared expertise, OneOncology will continue to strength community-based care across both oncology and urology, ensuring that patients receive world-class treatment close to home while reducing the overall cost of care.

About OneOncology
OneOncology was founded by community oncologists, for community oncologists, with the mission of improving the lives of everyone living with cancer. Our goal is to enable community oncology practices to remain independent and to improve patient access to care in their communities, all at a lower cost than in the hospital setting. OneOncology supports our platform of community oncology practices through group purchasing, operational optimization, data analytics, practice growth, and clinical innovation. Our 1,750 cancer care providers care for approximately 1 million patients at more than 565 sites of care nationwide. To learn more, visit oneoncology.com or LinkedIn.

SOURCE OneOncology, LLC.